where can i inject my tirzepatide Microdosing Explained: Injection Journey Tirzepatide injection site thigh: guide

A 12.8% reduction (from 28.1 1.1 to 24.5 2.8 g) in body weight was observed after two weeks of AngII-infusion compared to the Sham-operated animals

However, there is no scientific consensus supporting its efficacy or safety when used in this way

A 2023 case report in Cureus (Mizumoto) described a patient taking tirzepatide who developed an expanding skin reaction that extended over a large area over approximately ten days (Mizumoto, Cureus , PMC10575762)

doi: 10.5005/jp-journals-10018-1159 79

however, no differences between ALCAR and placebo were apparent at week 104 (92)

No human study has established a route conversion or shown that they match oral exposure